| Dr Alison R Stewart, DO | |
|
11333 N Sepulveda Blvd, Mission Hills, CA 91345-1116 | |
| (818) 869-7200 | |
| Not Available |
| Full Name | Dr Alison R Stewart |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Experience | 24 Years |
| Location | 11333 N Sepulveda Blvd, Mission Hills, California |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1487735163 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 20A9947 (California) | Primary |
| 207P00000X | Emergency Medicine | 036108148 (Illinois) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Whittier Hospital Medical Center | Whittier, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Gem Medical Group Corporation | 3072984400 | 51 |
News Archive
Data from one of the largest infant vaccine trials ever conducted, published in the New England Journal of Medicine (NEJM), showed GlaxoSmithKline's (GSK) rotavirus vaccine candidate as effective against rotavirus disease (rotavirus gastroenteritis) in the first year of life. Rotavirus is the leading recognized cause of diarrhea-related illness and death among infants and young children.
The Washington Post: "Opposition to the landmark health care overhaul declined over the past month, to 35 percent from 41 percent, according to the latest results of a tracking poll, reported Thursday. Fifty percent of the public held a favorable view of the law, up slightly from 48 percent a month ago, while 14 percent expressed no opinion about the measure, according to the poll by the Kaiser Family Foundation.
Resolvyx Pharmaceuticals, Inc., the leading Resolvin therapeutics company, today announced that the U.S. Patent and Trademark Office has granted a patent (U.S. Patent 7,582,785) covering composition of matter for RX-10045, the first Resolvin therapeutic to enter clinical trials.
ProPublica, Reuters and The Huffington Post won gold, silver and bronze awards, respectively, in the eighth annual Barlett & Steele Awards for Investigative Business Journalism, the Donald W. Reynolds National Center for Business Journalism announced today.
› Verified 7 days ago
| Entity Name | Glendale Emergency Medical Associates, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588606834 PECOS PAC ID: 0648269001 Enrollment ID: O20040510001673 |
News Archive
Data from one of the largest infant vaccine trials ever conducted, published in the New England Journal of Medicine (NEJM), showed GlaxoSmithKline's (GSK) rotavirus vaccine candidate as effective against rotavirus disease (rotavirus gastroenteritis) in the first year of life. Rotavirus is the leading recognized cause of diarrhea-related illness and death among infants and young children.
The Washington Post: "Opposition to the landmark health care overhaul declined over the past month, to 35 percent from 41 percent, according to the latest results of a tracking poll, reported Thursday. Fifty percent of the public held a favorable view of the law, up slightly from 48 percent a month ago, while 14 percent expressed no opinion about the measure, according to the poll by the Kaiser Family Foundation.
Resolvyx Pharmaceuticals, Inc., the leading Resolvin therapeutics company, today announced that the U.S. Patent and Trademark Office has granted a patent (U.S. Patent 7,582,785) covering composition of matter for RX-10045, the first Resolvin therapeutic to enter clinical trials.
ProPublica, Reuters and The Huffington Post won gold, silver and bronze awards, respectively, in the eighth annual Barlett & Steele Awards for Investigative Business Journalism, the Donald W. Reynolds National Center for Business Journalism announced today.
› Verified 7 days ago
| Entity Name | Michael S. Agron, M.d., Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699716100 PECOS PAC ID: 2668360736 Enrollment ID: O20040707000788 |
News Archive
Data from one of the largest infant vaccine trials ever conducted, published in the New England Journal of Medicine (NEJM), showed GlaxoSmithKline's (GSK) rotavirus vaccine candidate as effective against rotavirus disease (rotavirus gastroenteritis) in the first year of life. Rotavirus is the leading recognized cause of diarrhea-related illness and death among infants and young children.
The Washington Post: "Opposition to the landmark health care overhaul declined over the past month, to 35 percent from 41 percent, according to the latest results of a tracking poll, reported Thursday. Fifty percent of the public held a favorable view of the law, up slightly from 48 percent a month ago, while 14 percent expressed no opinion about the measure, according to the poll by the Kaiser Family Foundation.
Resolvyx Pharmaceuticals, Inc., the leading Resolvin therapeutics company, today announced that the U.S. Patent and Trademark Office has granted a patent (U.S. Patent 7,582,785) covering composition of matter for RX-10045, the first Resolvin therapeutic to enter clinical trials.
ProPublica, Reuters and The Huffington Post won gold, silver and bronze awards, respectively, in the eighth annual Barlett & Steele Awards for Investigative Business Journalism, the Donald W. Reynolds National Center for Business Journalism announced today.
› Verified 7 days ago
| Entity Name | East Valley Emergency Medical Associates, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346287430 PECOS PAC ID: 3870579691 Enrollment ID: O20050506000210 |
News Archive
Data from one of the largest infant vaccine trials ever conducted, published in the New England Journal of Medicine (NEJM), showed GlaxoSmithKline's (GSK) rotavirus vaccine candidate as effective against rotavirus disease (rotavirus gastroenteritis) in the first year of life. Rotavirus is the leading recognized cause of diarrhea-related illness and death among infants and young children.
The Washington Post: "Opposition to the landmark health care overhaul declined over the past month, to 35 percent from 41 percent, according to the latest results of a tracking poll, reported Thursday. Fifty percent of the public held a favorable view of the law, up slightly from 48 percent a month ago, while 14 percent expressed no opinion about the measure, according to the poll by the Kaiser Family Foundation.
Resolvyx Pharmaceuticals, Inc., the leading Resolvin therapeutics company, today announced that the U.S. Patent and Trademark Office has granted a patent (U.S. Patent 7,582,785) covering composition of matter for RX-10045, the first Resolvin therapeutic to enter clinical trials.
ProPublica, Reuters and The Huffington Post won gold, silver and bronze awards, respectively, in the eighth annual Barlett & Steele Awards for Investigative Business Journalism, the Donald W. Reynolds National Center for Business Journalism announced today.
› Verified 7 days ago
| Entity Name | Team Physicians Of Southern California Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225499015 PECOS PAC ID: 0446545354 Enrollment ID: O20160816003061 |
News Archive
Data from one of the largest infant vaccine trials ever conducted, published in the New England Journal of Medicine (NEJM), showed GlaxoSmithKline's (GSK) rotavirus vaccine candidate as effective against rotavirus disease (rotavirus gastroenteritis) in the first year of life. Rotavirus is the leading recognized cause of diarrhea-related illness and death among infants and young children.
The Washington Post: "Opposition to the landmark health care overhaul declined over the past month, to 35 percent from 41 percent, according to the latest results of a tracking poll, reported Thursday. Fifty percent of the public held a favorable view of the law, up slightly from 48 percent a month ago, while 14 percent expressed no opinion about the measure, according to the poll by the Kaiser Family Foundation.
Resolvyx Pharmaceuticals, Inc., the leading Resolvin therapeutics company, today announced that the U.S. Patent and Trademark Office has granted a patent (U.S. Patent 7,582,785) covering composition of matter for RX-10045, the first Resolvin therapeutic to enter clinical trials.
ProPublica, Reuters and The Huffington Post won gold, silver and bronze awards, respectively, in the eighth annual Barlett & Steele Awards for Investigative Business Journalism, the Donald W. Reynolds National Center for Business Journalism announced today.
› Verified 7 days ago
| Entity Name | Gem Medical Group Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689364721 PECOS PAC ID: 3072984400 Enrollment ID: O20230124000274 |
News Archive
Data from one of the largest infant vaccine trials ever conducted, published in the New England Journal of Medicine (NEJM), showed GlaxoSmithKline's (GSK) rotavirus vaccine candidate as effective against rotavirus disease (rotavirus gastroenteritis) in the first year of life. Rotavirus is the leading recognized cause of diarrhea-related illness and death among infants and young children.
The Washington Post: "Opposition to the landmark health care overhaul declined over the past month, to 35 percent from 41 percent, according to the latest results of a tracking poll, reported Thursday. Fifty percent of the public held a favorable view of the law, up slightly from 48 percent a month ago, while 14 percent expressed no opinion about the measure, according to the poll by the Kaiser Family Foundation.
Resolvyx Pharmaceuticals, Inc., the leading Resolvin therapeutics company, today announced that the U.S. Patent and Trademark Office has granted a patent (U.S. Patent 7,582,785) covering composition of matter for RX-10045, the first Resolvin therapeutic to enter clinical trials.
ProPublica, Reuters and The Huffington Post won gold, silver and bronze awards, respectively, in the eighth annual Barlett & Steele Awards for Investigative Business Journalism, the Donald W. Reynolds National Center for Business Journalism announced today.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Alison R Stewart, DO Po Box 9602, Mission Hills, CA 91346-9602 Ph: (818) 837-5559 | Dr Alison R Stewart, DO 11333 N Sepulveda Blvd, Mission Hills, CA 91345-1116 Ph: (818) 869-7200 |
News Archive
Data from one of the largest infant vaccine trials ever conducted, published in the New England Journal of Medicine (NEJM), showed GlaxoSmithKline's (GSK) rotavirus vaccine candidate as effective against rotavirus disease (rotavirus gastroenteritis) in the first year of life. Rotavirus is the leading recognized cause of diarrhea-related illness and death among infants and young children.
The Washington Post: "Opposition to the landmark health care overhaul declined over the past month, to 35 percent from 41 percent, according to the latest results of a tracking poll, reported Thursday. Fifty percent of the public held a favorable view of the law, up slightly from 48 percent a month ago, while 14 percent expressed no opinion about the measure, according to the poll by the Kaiser Family Foundation.
Resolvyx Pharmaceuticals, Inc., the leading Resolvin therapeutics company, today announced that the U.S. Patent and Trademark Office has granted a patent (U.S. Patent 7,582,785) covering composition of matter for RX-10045, the first Resolvin therapeutic to enter clinical trials.
ProPublica, Reuters and The Huffington Post won gold, silver and bronze awards, respectively, in the eighth annual Barlett & Steele Awards for Investigative Business Journalism, the Donald W. Reynolds National Center for Business Journalism announced today.
› Verified 7 days ago
Scott A Wang, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 15031 Rinaldi St, Mission Hills, CA 91345 Phone: 818-365-8051 | |
Jay J Brown, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 15031 Rinaldi St, Mission Hills, CA 91345 Phone: 818-365-8051 Fax: 818-898-4569 | |
Kiumars Arfai, MD Emergency Medicine Medicare: May Accept Medicare Assignments Practice Location: 11550 Indian Hills Rd, Suite 340, Mission Hills, CA 91345 Phone: 818-361-4959 Fax: 818-361-4951 | |
Bruce W. Cummings, D.O. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 15031 Rinaldi St, Mission Hills, CA 91345 Phone: 818-365-8051 Fax: 818-898-4569 | |
Charles Deng, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 15031 Rinaldi St, Mission Hills, CA 91345 Phone: 818-365-8051 | |
Thomas J Waskiewicz, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 15031 Rinaldi St, Mission Hills, CA 91345 Phone: 818-365-8051 |